Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akoya Biosciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AKYA
Nasdaq
3841
https://www.akoyabio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akoya Biosciences Inc
Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
- May 14th, 2024 1:01 pm
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
- May 13th, 2024 9:35 pm
Akoya Biosciences Reports First Quarter 2024 Financial Results
- May 13th, 2024 8:00 pm
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
- May 9th, 2024 12:00 pm
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- May 6th, 2024 2:00 pm
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
- May 6th, 2024 12:00 pm
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
- May 2nd, 2024 12:00 pm
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
- Apr 22nd, 2024 8:05 pm
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
- Apr 5th, 2024 12:00 pm
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript
- Mar 5th, 2024 2:52 pm
Q4 2023 Akoya Biosciences Inc Earnings Call
- Mar 5th, 2024 12:00 pm
Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook
- Mar 4th, 2024 10:31 pm
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
- Mar 4th, 2024 10:15 pm
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
- Mar 4th, 2024 9:05 pm
Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?
- Feb 29th, 2024 2:40 pm
Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m
- Feb 24th, 2024 12:57 pm
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
- Feb 13th, 2024 2:40 pm
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
- Feb 8th, 2024 9:05 pm
Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?
- Feb 7th, 2024 9:13 am
Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag
- Jan 31st, 2024 4:50 pm
Scroll